How do Monoclonal Antibodies work?

Monoclonal antibodies are proteins that are made from one type of antibody molecule. They are engineered to recognize specific molecules and can be used to treat diseases. Monoclonal antibodies were first developed in the 1950s and 1960s, but it wasn’t until the 1990s that they began being used in clinical trials for cancer treatments.

Today, monoclonal antibodies are one of the most commonly used types of cancer treatments. Monoclonal antibodies are generally used to treat diseases caused by abnormal cells (e.g., cancers). They are also used in the treatment of autoimmune diseases such as lupus, rheumatoid arthritis, and multiple sclerosis.Monoclonal antibodies can target almost any protein that is causing a disease. If you want to know more about Monoclonal Antibodies work you may navigate to :

Image Source:Google

That makes them a very effective type of cancer treatment because they’re specific and highly targeted to the tumor. Monoclonal antibodies attach to their target protein on the cancer cell and mark it for destruction by white blood cells called cytotoxic T-lymphocytes (CTLs).

This process is so fast that within hours or days the CTLs begin attacking and destroying the tumor cells.Monoclonal antibodies come in several forms including:Human monoclonal antibodies were first licensed for use in human patients in 1986 with the approval of a vaccine against hepatitis B.They have since been used to treat a wide range of diseases, from cancer to the flu and even diseases of the heart and lungs.